Physician profile
Benjamin Kim
NPI 1083103071
$2,412.63
in general payments reported to CMS, 2019-2025
20 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,087 · 2024: $1,002 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.82 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $586.69 | 2023-2025 | Prospera, Biotronik |
| Medtronic, INC. | $348.08 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $334.70 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $318.81 | 2023 | Senza |
| Abbott Laboratories | $195.82 | 2024 | Eterna, Proclaim |
| Globus Medical, INC. | $125.60 | 2025 | Senza |
| Spr Therapeutics, INC | $118.67 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $77.52 | 2023-2024 | |
| Bioventus LLC | $64.06 | 2024 | Stimrouter Implantable Kit |
| Si-Bone, INC. | $32.56 | 2024 | |
| Pfizer INC. | $30.66 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.25 | 2024-2025 | Relistor |
| Averitas Pharma INC. | $29.35 | 2023 | Qutenza |
| Vertos Medical, INC. | $23.06 | 2023 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $21.97 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $16.15 | 2024 | Brixadi |
| Pacira Pharmaceuticals Incorporated | $15.92 | 2024 | Zilretta, Iovera |
| Electronic Waveform Lab, INC. | $15.74 | 2023 | |
| Ibsa Pharma INC. | $13.94 | 2023 | Tirosint, Licart |
| Collegium Pharmaceutical, INC. | $13.08 | 2024 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.